Literature DB >> 21745550

Use of apigenin from Cordia dichotoma in the treatment of colitis.

Anjali B Ganjare1, Sunil A Nirmal, Anuja N Patil.   

Abstract

Cordia dichotoma f. (Boraginaceae) is a small deciduous tree from India. The bark of was used in the treatment of ulcerative colitis (UC) and colic pain traditionally hence present work was undertaken to identify the phytoconstituent responsible for this activity. Apigenin is isolated by column chromatography from methanol fraction of crude methanol extract of C. dichotoma bark. Structure of apigenin is established by various spectroscopic studies. Apigenin (5mg/kg, p.o.) showed significant healing and reduction in inflammatory enzymes when screened for UC. It can be concluded that apigenin from C. dichotoma bark may be responsible for the treatment of UC.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745550     DOI: 10.1016/j.fitote.2011.06.008

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  7 in total

Review 1.  Plant profile, phytochemistry and pharmacology of Cordia dichotoma (Indian cherry): a review.

Authors:  Prasad G Jamkhande; Sonal R Barde; Shailesh L Patwekar; Priti S Tidke
Journal:  Asian Pac J Trop Biomed       Date:  2013-12

2.  A dietary flavone confers communicable protection against colitis through NLRP6 signaling independently of inflammasome activation.

Authors:  K Radulovic; S Normand; A Rehman; A Delanoye-Crespin; J Chatagnon; M Delacre; N Waldschmitt; L F Poulin; J Iovanna; B Ryffel; P Rosenstiel; M Chamaillard
Journal:  Mucosal Immunol       Date:  2017-11-15       Impact factor: 7.313

Review 3.  Pharmacological Effects of Polyphenol Phytochemicals on the Intestinal Inflammation via Targeting TLR4/NF-κB Signaling Pathway.

Authors:  Caiyun Yu; Dong Wang; Zaibin Yang; Tian Wang
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 4.  Therapeutic Potential of Flavonoids in Pain and Inflammation: Mechanisms of Action, Pre-Clinical and Clinical Data, and Pharmaceutical Development.

Authors:  Camila R Ferraz; Thacyana T Carvalho; Marília F Manchope; Nayara A Artero; Fernanda S Rasquel-Oliveira; Victor Fattori; Rubia Casagrande; Waldiceu A Verri
Journal:  Molecules       Date:  2020-02-10       Impact factor: 4.411

5.  Apigenin-Mn(II) loaded hyaluronic acid nanoparticles for ulcerative colitis therapy in mice.

Authors:  Feng Lv; Yuchen Zhang; Qiao Peng; Xinxin Zhao; Datao Hu; Jinpeng Wen; Kailai Liu; Ruilin Li; Ke Wang; Jinyao Sun
Journal:  Front Chem       Date:  2022-07-22       Impact factor: 5.545

Review 6.  The significant impact of apigenin on different aspects of autoimmune disease.

Authors:  Neda Kasiri; Mahshid Rahmati; Leila Ahmadi; Nahid Eskandari
Journal:  Inflammopharmacology       Date:  2018-09-18       Impact factor: 5.093

Review 7.  Favorable results from the use of herbal and plant products in inflammatory bowel disease: evidence from experimental animal studies.

Authors:  John K Triantafillidis; Aikaterini Triantafyllidi; Constantinos Vagianos; Apostolos Papalois
Journal:  Ann Gastroenterol       Date:  2016-02-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.